Randomized double-blind placebo-controlled international trial of abago-vomab maintenance therapy in patients with advanced ovarian cancer after complete response to first-line chemotherapy: The Monoclonal Antibody Immunotherapy for Malignancies of the Ovary by Subcutaneous Abago-vomab (MIMOSA) trial Meeting Abstract
| Authors: | Pfisterer, J.; Berek, J. S.; Casado, A.; Cwiertka, K.; Pinter, T.; Pluzanska, A.; Pujade-Lauraine, E.; Scambia, G.; Vermorken, J. B.; Simonelli, C.; Bertolotti, M.; Capriati, A.; Sabbatini, P.; AGO-OVAR; COGI; GEICO; GINECO |
| Abstract Title: | Randomized double-blind placebo-controlled international trial of abago-vomab maintenance therapy in patients with advanced ovarian cancer after complete response to first-line chemotherapy: The Monoclonal Antibody Immunotherapy for Malignancies of the Ovary by Subcutaneous Abago-vomab (MIMOSA) trial |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-06-20 |
| Language: | English |
| ACCESSION: | WOS:000208865800022 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2011.29.18_suppl.lba5002 |
| Notes: | Meeting Abstract: LBA5002 -- Source: Wos |
